Head-to-head · WeighScore
CoraDoc vs Virta Health
The verdict
CoraDoc takes it — 76.8/100 to 59.7/100.
CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc is a nationwide (all 50 states) doctor-prescribed GLP-1 weight-loss telehealth service offering compounded semaglutide (from $99/mo) and tirzepatide (from $165/mo) as flat, no-subscription programs.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | CoraDoc | Virta Health |
|---|---|---|
| WeighScore | 76.8/100 | 59.7/100 |
| Grade | C | C |
| Scorecard rank | #49 | #336 |
| Semaglutide | $99/mo (all doses, compounded) | Not disclosed |
| Tirzepatide | $165/mo (all doses, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #49 · C
Strengths
- Low flat pricing — compounded semaglutide from $99/mo, tirzepatide from $165/mo, no subscription
- Triple Free Promise: free provider visit, free 2-day shipping, and free supplies included
- Available in all 50 states; HSA/FSA plus Afterpay/Klarna/Affirm; full refund if not approved
- Full legal suite published (Terms, Privacy, Refund Policy); board-certified providers
Where it loses points
- Lowest $99 price is the longest-commitment tier (programs range about $99-$199/mo)
- Compounding pharmacy partner not named
- 'LegitScript Certified' is stated prominently but was not independently verified here
- Operating legal entity not clearly named on the site
Graded #336 · C
Strengths
- Offers a Responsible Prescribing track with optimized GLP-1 use
- Clinically monitored medication off-ramp toward nutrition therapy
- Nutrition-first model shown to rival GLP-1 weight loss (about 13% at 1 year)
- Provided at no cost to members through employers and health plans
- Strong evidence base for diabetes reversal and metabolic health
Where it loses points
- Primarily a nutrition program; GLP-1s are a secondary track
- Distributed via employers and health plans, no direct cash-pay
- Deliberately discourages GLP-1 use for most members
- GLP-1 access depends on the specific program the plan selects
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.